Rani Therapeutics Hldgs
(NASDAQ:RANI)
$6.56
0[0.00%]
Last update: 7:44PM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Rani Therapeutics Hldgs Stock (NASDAQ:RANI), Quotes and News Summary

Rani Therapeutics Hldgs Stock (NASDAQ: RANI) stock price, news, charts, stock research, profile.

Open$6.480
Close-
Volume / Avg.16.504K / 129.340K
Day Range6.295 - 6.595
52 Wk Range1.820 - 8.750
Market Cap$172.519M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
62
Short Interest
14.62%
Days to Cover23.74

Recent News

Equifax Reports Weak Sales, Joins Synovus Financial And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining over 50 points on Thursday.
Avi Kapoor
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.
Avi Kapoor
Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Nov 23
1
Feb
2
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Rani Therapeutics Holdings Inc
Sector
Health Care
Industry
Pharmaceuticals
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RANI
ZVRA

FAQ

Q

How do I buy Rani Therapeutics Hldgs (RANI) stock?

A

You can purchase shares of Rani Therapeutics Hldgs (NASDAQ: RANI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Rani Therapeutics Hldgs's (RANI) competitors?

A

Other companies in Rani Therapeutics Hldgs’s space includes: Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Terns Pharma (NASDAQ:TERN), Alimera Sciences (NASDAQ:ALIM) and Telomir Pharmaceuticals (NASDAQ:TELO).

Q

What is the target price for Rani Therapeutics Hldgs (RANI) stock?

A

The latest price target for Rani Therapeutics Hldgs (NASDAQ: RANI) was reported by Canaccord Genuity on Wednesday, March 27, 2024. The analyst firm set a price target for 9.00 expecting RANI to rise to within 12 months (a possible 37.20% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Rani Therapeutics Hldgs (RANI)?

A

The stock price for Rani Therapeutics Hldgs (NASDAQ: RANI) is $6.56 last updated April 25, 2024 at 7:44 PM EDT.

Q

Does Rani Therapeutics Hldgs (RANI) pay a dividend?

A

There are no upcoming dividends for Rani Therapeutics Hldgs.

Q

When is Rani Therapeutics Hldgs (NASDAQ:RANI) reporting earnings?

A

Rani Therapeutics Hldgs’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Q

Is Rani Therapeutics Hldgs (RANI) going to split?

A

There is no upcoming split for Rani Therapeutics Hldgs.

Q

What sector and industry does Rani Therapeutics Hldgs (RANI) operate in?

A

Rani Therapeutics Hldgs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch